Cannabis Law Report

OCTOBER 5, 2021

Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions. An evaluation of the therapeutic value, benefits and risks of methylenedioxymethamphetamine (MDMA) and psilocybin for the treatment of mental, behavioural or developmental disorders.

Treatment 52

Treatment Conditions Medicine Clinical Trials 52

Canna Care Docs

OCTOBER 3, 2023

Conventional medication methods such as opiates may help terminal patients focus on more palliative treatment options and goals in order to better one’s comfort and overall quality of life during this time. One study from the Journal of Clinical Oncology examined the efficacy of cannabinoids in appetite stimulation.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Cannabis Law Report

OCTOBER 13, 2021

The PCT filing also includes support for future research programs respecting various systems which seek to minimize negative side effects in psychedelic psychotherapy patients, methods that enable lower and sub-psychedelic doses without impacting treatment efficacy and increasing the long-term efficacy of psychedelic sessions. About Cybin.

Clinical Trials 52

Clinical Trials Research and Development Treatment Conditions 52

Cannabis Law Report

AUGUST 3, 2021

Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. Cybin makes no medical, treatment or health benefit claims about Cybin’s proposed products.

Clinical Trials 105

Clinical Trials Events Treatment Banking 105

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

FloridaMarijuana.net

AUGUST 15, 2018

Additionally, the ACPA reported on a clinical trial that suggests that inhaled cannabis may provide short-term relief from Neuropathy. More than ever, cannabis can aid in the treatment of chronic disease and as a supplement to other medical interventions and treatments.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

Veriheal

JULY 12, 2021

For veterans, PTSD (sometimes referred to as ‘shell shock’ or ‘combat stress’) can severely impact their livelihood. and 30% of deployed and non-deployed veterans screened positive for PTSD, which is why the condition has been made a priority through various initiatives. .

Treatment 104

Treatment Sleep Clinical Trials Data 104

Cannabis Law Report

NOVEMBER 19, 2021

“These additional patent filings are key as PsyBio moves towards the initiation of appropriately approved safety and efficacy clinical trials for our selected compounds within the production and manufacturing arena, for the Company as well as for our investors.” Vigorous scientific research and clinical trials are needed.

Clinical Trials 52

Clinical Trials Research and Development Events Safety 52

The Cannigma

MAY 1, 2023

2 3 As clinical trials around the world proceeded in the late 1960s and 1970s, patients began reporting difficulty tolerating ketamine’s unpleasant hallucinogenic and dissociative properties. Ketamine was approved by the FDA in 1970 and was immediately put to use as an important tool for war medics in the Vietnam War.

Blood Pressure 80

Blood Pressure Chronic Pain Research and Development Clinical Trials 80

CannaMD

AUGUST 26, 2020

Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. Although several drugs have been investigated, there is no strong or consistent evidence indicating any of these drugs for the treatment of cocaine use disorder. Conditioned place preference.

Therapy 98

Therapy CBD Research and Development Treatment 98

Puff Puff Post

JANUARY 13, 2020

Currently, researchers at a number of university hospitals are investigating CBD’s potential usage as a treatment for autism. There are currently no approved prescriptions for autism, so if CBD oil gets approved as the first treatment for autism it will be a huge medical breakthrough. Chronic alcoholism is a serious health condition.

CBD 52

CBD Clinical Trials Research and Development Oil 52

Puff Puff Post

JANUARY 13, 2020

Currently, researchers at a number of university hospitals are investigating CBD’s potential usage as a treatment for autism. There are currently no approved prescriptions for autism, so if CBD oil gets approved as the first treatment for autism it will be a huge medical breakthrough. Chronic alcoholism is a serious health condition.

CBD 52

CBD Clinical Trials Research and Development Oil 52

Kind Meds (Cannabis Education Blog)

NOVEMBER 16, 2022

In fact, there are around 150 different cannabinoids that have been identified, all of which have their own unique characteristics and effects on the brain and body.The newest cannabinoid to take the stage is cannabinol, commonly referred to as CBN. CBN has the potential to treat many other conditions. Dental conditions.

Sleep 94

Sleep Cannabinoids THC CBD 94

Greencamp

FEBRUARY 17, 2019

Usually, the diagnosis involves excluding conditions like parasitic infections, lactose intolerance tests and small intestinal bacterial overgrowth which all produce symptoms like IBS. Constant gut symptoms often lead to the development of other conditions like anxiety , depression , migraines , sleeping problems and fatigue.

Digestion 96

Digestion Research and Development Marijuana Cannabinoids 96

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Based on my clinical experience, it is rare for people to experience CBD-drug interactions at doses below 100mg daily. . CBD and Immunosuppressant Medications.

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

DECEMBER 17, 2021

deletion syndrome clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases. The trial is currently registered with the Australian New Zealand Clinical Trials Registry (ANZCTR).

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Therapy 52

The Cannigma

DECEMBER 12, 2022

And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. Now, psychedelic research is booming. Are psychedelics safe?

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

MARCH 17, 2022

It is an effective treatment for various health conditions such as chronic pain, nausea, seizures, and more. In this context, ‘CBD oil’ refers specifically to cannabidiol oil produced from cannabis or hemp plants. However, there have been no such clinical trials done on the addictive potential of THC or CBD oil.

Oil 52

Oil CBD Chronic Pain Extraction 52

Miss Marijuana

MAY 13, 2020

What most people don’t understand is that CBD may be helpful for symptom management for conditions such as anxiety, inflammation, pain, sleep and certain types of seizures, however, figuring out how to achieve those effects is a bit more complicated. Topicals – These are a common way to use CBD for skin conditions or joint/pain issues.

CBD 98

CBD Blood Pressure Clinical Trials Tincture 98

Cannabis Law Report

DECEMBER 14, 2019

In October, some Canadian firms adjusted their global expansion plans in Australia due to the conditions seen in the cannabis industry. Now, unless the patient is under 16 years old or has a history of drug abuse, medical practitioners in New South Wales can prescribe cannabis medicines without having to refer to a specialist.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Cannabis Law Report

SEPTEMBER 24, 2019

We’re presuming both names “Epidyolex” & “Epidiolex” refer to exactly the same product and the former is the US product name and the latter the European brand name. These treatments can be prescribed only by specialist doctors in a limited number of circumstances where other medicines have failed.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease.

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Based on my clinical experience, it is rare for people to experience CBD-drug interactions at doses below 100mg daily. [2]. CBD and Immunosuppressant Medications.

CBD 52

CBD THC Conditions Medicine 52

Greencamp

AUGUST 16, 2018

The available body of evidence suggests that besides the lessening of symptoms, cannabis is also capable of slowing down the overall rate of progression of this horrible condition. Modern science hasn’t found a cure for this condition so far, and the most frequent cause of death is respiratory failure due to muscle decay. References.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Greencamp

FEBRUARY 2, 2019

Examples include pneumonia, cancers, tuberculosis, chronic diarrhea, and inflammation-based conditions such as meningitis and encephalitis. Depending on what type of cell it is, but also the type of condition a person is struggling with, these factors determine the way how will a specific cell react to cannabinoids.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

The Cannigma

JULY 1, 2022

Preclinical studies involve exposing cells and animals to treatments to see if there are indications that the treatment could be worth evaluating in humans. Clinical studies are performed in people and can be controlled in various ways to understand how people respond to a treatment.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The popularity of medical cannabinoids (MCs) treatment is growing, as more countries enable MCs treatment for various indications in adults 1. Metrics details. Introduction. Search strategy. 18 years old).

Safety 52

Safety Cannabinoids Events Data 52

Miss Marijuana

MAY 13, 2020

What most people don’t understand is that CBD may be helpful for symptom management for conditions such as anxiety, inflammation, pain, sleep and certain types of seizures, however, figuring out how to achieve those effects is a bit more complicated. Topicals – These are a common way to use CBD for skin conditions or joint/pain issues.

CBD 52

CBD Blood Pressure Clinical Trials Tincture 52

CannaMD

AUGUST 8, 2020

When people say they’re buying or using “CBD,” they’re referring to products (most often oils) that are rich in this compound. Prior to receiving FDA approval, Epidiolex underwent a number of clinical trials establishing the medical efficacy of CBD. What can CBD do? You’re in luck! Get Started.

CBD 99

CBD DEA Research and Development Hemp 99

Cannabis Law Report

JUNE 9, 2022

We understand the number of people who will need medical treatment due to this exposure. The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. ARV (revised).

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

Veriheal

JUNE 29, 2022

Consequently, psychedelics have received a significant amount of attention for ailments that are in need of more effective solutions, such as treatment-resistant depression (TRD). Exploring Psilocybin and Treatment-Resistant Depression. Future Trials With COMP360 Psilocybin. Dr. David J.

Clinical Trials 103

Clinical Trials Blood Pressure Treatment Therapy 103

Veriheal

SEPTEMBER 21, 2023

Now that the monsoon rains are in full swing, the heat and rain provide the perfect breeding condition for the amphibians. However, this year had an anomaly because the monsoon’s first conditions kicked in on July 17 , alongside a record-breaking temperature. However, it is also commonly referred to as the Colorado River toad.

Clinical Trials 113

Clinical Trials Therapy Conditions Pets 113

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. tetrahydrocannabinol (THC).

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Veriheal

JUNE 29, 2021

In order to legally access other therapies including nature-based options such as psilocybin , you must gain access under a Right to Try law which requires you to have a terminal condition. The FDA refers to this program as the expanded access program on their website. Introducing the Right to Try Act.

Therapy 55

Therapy DEA Patients Clinical Trials 55

FloridaMarijuana.net

AUGUST 13, 2018

Florida medical marijuana doctors are recommending medical marijuana for anxiety, depression and many other mental health conditions. Anxiety is one aspect of a broader condition- anxiety disorder. There are a variety of treatment options to help patients cope with and heal from anxiety disorders.

Marijuana 145

Marijuana Patients Clinical Trials Conditions 145

Cannabis Law Report

JANUARY 26, 2022

MDMA as an adjunct to therapy for PTSD is the forty-first treatment to receive the Innovation Passport since its inception in January 2021. The designation is intended to accelerate the timeline for approval of innovative medicines for treatment of life-threatening conditions or those which present a significant patient or public health need.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Cannabis Law Report

JULY 28, 2021

Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options. Advance to FDA IND-enabling studies to support human clinical studies. Previously the Company announced that it had secured FDA Orphan Drug Designation for cepharanthine in the treatment of esophageal cancer.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105